Elevated lipoprotein(a) (Lp(a)) has emerged as an important independent cardiovascular risk factor, and causal association has been accepted with adverse outcome in atherosclerotic disease. Lipoprotei...

Therapeutic plasma exchange (TPE) in pediatric patients presents many challenges, including management of a large extracorporeal volume (ECV) and calcium replacement for patients who may not be able ...

Introduction High-dose online HDF compared with hemodialysis reduces all-cause mortality, but increases water consumption. We postulate that the conundrum could be solved by individualizing dialysat...

Lipoprotein apheresis (LA) remains a critical therapeutic approach for patients with severe lipid disorders, particularly those who fail to achieve ta…

Apheresis is used for the treatment of many different diseases, especially when conventional therapy lacks efficacy. There are however some diseases in which apheresis is accepted as first line therap...

We report a 15-year-old boy with severe septic shock and multiple organ failure, requiring intensive care and extracorporeal therapies, including veno-arterial extracorporeal membrane oxygenation, con...

The global apheresis equipment market was valued at USD 2.5 billion in 2024 and is expected to grow at a CAGR of 7.0% from 2025 to 2034. The market is driven by growing applications in therapeutic plasma exchange and blood component separation. Market Definition The Apheresis Equipment Market revolves around medical devices that perform extracorporeal blood separation to collect or remove specific components—such as plasma, platelets, red cells, leukocytes, or stem cells—returning the remaining blood back to the donor or patient. These systems utilize technologies like centrifugation and membrane filtration to support applications across blood donation centers, hospitals, and therapeutic settings—such as leukapheresis, plasmapheresis, stem cell harvesting, and therapeutic plasma exchange (TPE).